LIST OF TABLES
TABLE 01. GLOBAL IMMUNOGLOBULIN MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 02. GLOBAL IMMUNOGLOBULIN MARKET, BY APPLICATION, 20172025 (KILOGRAM)
TABLE 03. GLOBAL IMMUNOGLOBULIN MARKET, FOR HYPOGAMMAGLOBULINEMIA, BY REGION, 20172025 ($MILLION)
TABLE 04. GLOBAL IMMUNOGLOBULIN MARKET, FOR CIPD, BY REGION, 20172025 ($MILLION)
TABLE 05. GLOBAL IMMUNOGLOBULIN MARKET, FOR CIPD, BY REGION, 20172025 (KILOGRAMS)
TABLE 06. GLOBAL IMMUNOGLOBULIN MARKET, FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA BY REGION, 20172025 ($MILLION)
TABLE 07. GLOBAL IMMUNOGLOBULIN MARKET, FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA BY REGION, 20172025 (KILOGRAMS)
TABLE 08. GLOBAL IMMUNOGLOBULIN MARKET, FOR MYASTHENIA GRAVIS (MG), BY REGION, 20172025 ($MILLION)
TABLE 09. GLOBAL IMMUNOGLOBULIN MARKET, FOR MYASTHENIA GRAVIS (MG), BY REGION, 20172025 (KILOGRAMS)
TABLE 10. GLOBAL IMMUNOGLOBULIN MARKET, FOR MULTIFOCAL MOTOR NEUROPATHY, BY REGION, 20172025 ($MILLION)
TABLE 11. GLOBAL IMMUNOGLOBULIN MARKET, FOR MULTIFOCAL MOTOR NEUROPATHY, BY REGION, 20172025 (KILOGRAMS)
TABLE 12. GLOBAL IMMUNOGLOBULIN MARKET, FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), BY REGION, 20172025 ($MILLION)
TABLE 13. GLOBAL IMMUNOGLOBULIN MARKET, FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), BY REGION, 20172025 (KILOGRAMS)
TABLE 14. GLOBAL IMMUNOGLOBULIN MARKET, FOR INFLAMMATORY MYOPATHY, BY REGION, 20172025 ($MILLION)
TABLE 15. GLOBAL IMMUNOGLOBULIN MARKET, FOR INFLAMMATORY MYOPATHY, BY REGION, 20172025 (KILOGRAMS)
TABLE 16. GLOBAL IMMUNOGLOBULIN MARKET, FOR SPECIFIC ANTIBODY DEFICIENCY (SAD), BY REGION, 20172025 ($MILLION)
TABLE 17. GLOBAL IMMUNOGLOBULIN MARKET, FOR SPECIFIC ANTIBODY DEFICIENCY (SAD), BY REGION, 20172025 (KILOGRAMS)
TABLE 18. GLOBAL IMMUNOGLOBULIN MARKET, FOR GUILLAIN-BARRE SYNDROME, BY REGION, 20172025 ($MILLION)
TABLE 19. GLOBAL IMMUNOGLOBULIN MARKET, FOR GUILLAIN-BARRE SYNDROME), BY REGION, 20172025 (KILOGRAMS)
TABLE 20. GLOBAL IMMUNOGLOBULIN MARKET, FOR OTHERS, BY REGION, 20172025 ($MILLION)
TABLE 21. GLOBAL IMMUNOGLOBULIN MARKET, FOR OTHERS, BY REGION, 20172025 (KILOGRAMS)
TABLE 22. GLOBAL IMMUNOGLOBULIN MARKET, BY MODE OF DELIVERY, 20172025 ($MILLION)
TABLE 23. GLOBAL IMMUNOGLOBULIN MARKET, BY MODE OF DELIVERY, 20172025 (KILOGRAMS)
TABLE 24. IMMUNOGLOBULIN MARKET, FOR INTRAVENOUS, BY REGION, 20172025 ($MILLION)
TABLE 25. IMMUNOGLOBULIN MARKET, FOR INTRAVENOUS, BY REGION, 20172025 (KILOGRAMS)
TABLE 26. IMMUNOGLOBULIN MARKET, FOR 5% CONCENTRATION, BY REGION, 20172025 ($MILLION)
TABLE 27. IMMUNOGLOBULIN MARKET, FOR 10% CONCENTRATION, 20172025 ($MILLION)
TABLE 28. GLOBAL IMMUNOGLOBULIN MARKET, FOR OTHER CONCENTRATIONS, 20172025 ($MILLION)
TABLE 29. IMMUNOGLOBULIN MARKET, FOR SUBCUTANEOUS MODE OF DELIVERY, BY REGION, 20172025 ($MILLION)
TABLE 30. IMMUNOGLOBULIN MARKET, FOR SUBCUTANEOUS MODE OF DELIVERY, BY REGION, 20172025 (KILOGRAMS)
TABLE 31. GLOBAL IMMUNOGLOBULIN MARKET, BY REGION, 20172025 ($MILLION)
TABLE 32. GLOBAL IMMUNOGLOBULIN MARKET, BY REGION, 20172025 (KILOGRAMS)
TABLE 33. NORTH AMERICA IMMUNOGLOBULIN MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 34. NORTH AMERICA IMMUNOGLOBULIN MARKET, BY COUNTRY, 20172025 (KILOGRAMS)
TABLE 35. NORTH AMERICA IMMUNOGLOBULIN MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 36. NORTH AMERICA IMMUNOGLOBULIN MARKET, BY TARGET AREA, 20172025 ($MILLION)
TABLE 37. EUROPE IMMUNOGLOBULIN MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 38. EUROPE IMMUNOGLOBULIN MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 39. EUROPE IMMUNOGLOBULIN MARKET, BY MODE OF DELIVERY, 20172025 ($MILLION)
TABLE 40. ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 41. ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 42. ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY MODE OF DELIVERY, 20172025 ($MILLION)
TABLE 43. LAMEA IMMUNOGLOBULIN MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 44. LAMEA IMMUNOGLOBULIN MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 45. LAMEA IMMUNOGLOBULIN MARKET, BY MODE OF DELIVERY, 20172025 ($MILLION)
TABLE 46. BAXTER: COMPANY SNAPSHOT
TABLE 47. BAXTER: OPERATING SEGMENTS
TABLE 48. BAXTER: PRODUCT PORTFOLIO
TABLE 49. BIOTEST: COMPANY SNAPSHOT
TABLE 50. BIOTEST: OPERATING SEGMENTS
TABLE 51. BIOTEST: OPERATING SEGMENT
TABLE 52. CSL: COMPANY SNAPSHOT
TABLE 53. CSL: PRODUCT SEGMENTS
TABLE 54. CSL: PRODUCT PORTFOLIO
TABLE 55. GRIFOLS: COMPANY SNAPSHOT
TABLE 56. GRIFOLS: OPERATING SEGMENTS
TABLE 57. GRIFOLS: PRODUCT PORTFOLIO
TABLE 58. LFB: COMPANY SNAPSHOT
TABLE 59. LFB: PRODUCT SEGMENTS
TABLE 60. LFB: PRODUCT PORTFOLIO
TABLE 61. OCTAPHARMA: COMPANY SNAPSHOT
TABLE 62. OCTAPHARMA: PRODUCT SEGMENTS
TABLE 63. OCTAPHARMA: PRODUCT PORTFOLIO
TABLE 64. BAYER: COMPANY SNAPSHOT
TABLE 65. BAYER: OPERATING SEGMENTS
TABLE 66. KEDRION: COMPANY SNAPSHOT
TABLE 67. KEDRION: PRODUCT PORTFOLIO
TABLE 68. SHIRE: COMPANY SNAPSHOT
TABLE 69. SHIRE: PRODUCT PORTFOLIO
TABLE 70. CHINA BIOLOGIC COMPANY SNAPSHOT
TABLE 71. CHINA BIOLOGIC PRODUCT PORTFOLIO LIST OF FIGURES
FIGURE 01. IMMUNOGLOBULIN MARKET SEGMENTATION
FIGURE 02. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*
FIGURE 03. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)
FIGURE 04. TOP WINNING STRATEGIES, BY COMPANY, 2015-2018*
FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 06. HIGH BARGAINING POWER OF BUYERS
FIGURE 07. HIGH THREAT OF SUBSTITUTION
FIGURE 08. HIGH THREAT OF NEW ENTRANTS
FIGURE 09. HIGH COMPETITIVE RIVALRY
FIGURE 10. MARKET SHARE ANALYSIS, 2017
FIGURE 11. GLOBAL IMMUNOGLOBULIN MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 01. U.S. IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 02. CANADA IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 03. MEXICO IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 04. GERMANY IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 05. FRANCE IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 06. UK IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 07. ITALY IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 08. SPAIN IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 09. RUSSIA IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 10. REST OF EUROPE IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 11. JAPAN IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 12. CHINA IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 13. INDIA IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 14. AUSTRALIA IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 15. AUSTRALIA IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 16. TAIWAN IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 17. REST OF ASIA-PACIFIC IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 18. BRAZIL IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 19. SOUTH AFRICA IMMUNOGLOBULIN MARKET, 2017-2025 ($ MILLION)
FIGURE 20. SAUDI ARABIA IMMUNOGLOBULIN MARKET, 20172025 ($MILLION)
FIGURE 21. ARGENTINA IMMUNOGLOBULIN MARKET, 20172025 ($MILLION)
FIGURE 22. REST OF LAMEA IMMUNOGLOBULIN MARKET, 20172025 ($MILLION)
FIGURE 23. BAXTER: NET SALES, 20152017 ($MILLION)
FIGURE 24. BAXTER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 25. BAXTER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 26. BIOTEST: NET SALES, 20152017 ($MILLION)
FIGURE 27. BIOTEST: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 28. BIOTEST: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 29. CSL: NET SALES, 20152017 ($MILLION)
FIGURE 30. CSL: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 31. CSL: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 32. GRIFOLS: NET SALES, 20152017 ($MILLION)
FIGURE 33. GRIFOLS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 34. GRIFOLS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 35. LFB: NET SALES, 20142016 ($MILLION)
FIGURE 36. LFB: REVENUE SHARE BY PRODUCT SEGMENT, 2016 (%)
FIGURE 37. LFB: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 38. OCTAPHARMA: NET SALES, 20152017 ($MILLION)
FIGURE 39. BAYER: NET SALES, 20152017 ($MILLION)
FIGURE 40. BAYER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 41. BAYER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 42. KEDRION: NET SALES, 20152017 ($MILLION)
FIGURE 43. KEDRION: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 44. SHIRE: NET SALES, 20152017 ($MILLION)
FIGURE 45. SHIRE: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 46. SHIRE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 47. CHINA BIOLOGIC NET SALES, 20152017 ($MILLION